{"title":"Activity Detection and Inhibitor Development of GH92 Mannosidase Derived from Streptococcus pneumoniae","authors":"Ryosuke Koyama","doi":"10.4052/tigg.2336.6j","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":55609,"journal":{"name":"Trends in Glycoscience and Glycotechnology","volume":"101 1","pages":""},"PeriodicalIF":0.2000,"publicationDate":"2023-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Trends in Glycoscience and Glycotechnology","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.4052/tigg.2336.6j","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
期刊介绍：
TIGG is an international, bilingual journal covering glycoscience and glycotechnology and issued bimonthly since 1989. Since then editors are elected from academia and companies who agree to participate in a volunteer basis for the duration of four years.
TIGG is an official journal of the Japanese Society of Carbohydrate Research.
The journal covers the following categories.
MINIREVIEWS describe recent progress in the fields of glycoscience and glycotechnology. Suggestions are always welcome in the form of a one-page synopsis (double spaced) addressed to the editor-in-chief.
GLYCOTOPICS are short commentaries on the latest papers describing outstanding findings with background.
GLYCODEBUTS introduce distinguished PhD theses or outstanding works of young scientists over the world in glycosciences and glycotechnologies.
GLYCOFORUM is for our readers who wish to submit comments on scientific or social matters related to glycoscience and glycotechnology.
LETTERS TO TIGG are for readers who wish to discuss contributions appearing in TIGG or matters related to FCCA.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
